MedPath

LAPIDAR 14 TAB

LAPIDAR 14 TAB

Discontinued
DIN Number

00445428

Drug Class

Human

Market Date

Dec 31, 1976

Company
HC

swiss herbal remedies ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00445428
AIG Number0813058001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:01.00*
Health Canada Classification

ACTIVE INGREDIENTS (8)

ANISEActive
Strength: 8 MG / TAB
Monograph: ANISE
BETULA PENDULA FOLIAActive
Strength: 8 MG / TAB
Monograph: BETULA PENDULA FOLIA
CARAWAYActive
Strength: 8 MG / TAB
Monograph: CARAWAY
CORIANDERActive
Strength: 8 MG / TAB
Monograph: CORIANDER
FENNELActive
Strength: 12 MG / TAB
Monograph: FENNEL
FUCUS VESICULOSUSActive
Strength: 12 MG / TAB
Monograph: FUCUS VESICULOSUS
GLYCYRRHIZA GLABRAActive
Strength: 12 MG / TAB
Monograph: GLYCYRRHIZA GLABRA
JUNIPER BERRIESActive
Strength: 8 MG / TAB
Monograph: JUNIPER BERRIES

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.